A Win For F-star Therapeutics Inc.

Thu, Jun 23, 2022 at 08:30 PM

F-star Therapeutics Inc. (FSTX:NASDAQ) rocketted at $6.36, representing a gain of 59.8%. On Thu, Jun 23, 2022, FSTX:NASDAQ touched a New 2-Week High of $6.36. The stock got featured on our News Catalysts scanner on Thu, Jun 23, 2022 at 08:29 AM in the 'BIOTECH' category. From Thu, Jun 09, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days

About F-star Therapeutics Inc. (FSTX:NASDAQ)

F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy.

Top 10 Gainers:

Fujian Blue Hat Interactive Entertainment Technology Ltd. (BHAT:NASDAQ), 263.03%
RISE Education Cayman Ltd (REDU:NASDAQ), 138.46%
F-star Therapeutics Inc. (FSTX:NASDAQ), 59.8%
TDH Holdings, Inc. (PETZ:NASDAQ), 54.74%
Vroom Inc. (VRM:NASDAQ), 36.44%
Rain Therapeutics Inc. (RAIN:NASDAQ), 32.82%
Molecular Data Inc. (MKD:NASDAQ), 32.18%
Cardiff Oncology Inc. (CRDF:NASDAQ), 31.61%
22nd Century Group Inc (XXII:NASDAQ), 31.12%
9 Meters Biopharma, Inc. (NMTR:NASDAQ), 31.11%